Frequently Asked Questions
Common Questions About Using ICD-10 Code G23.1 for Progressive supranuclear ophthalmoplegia
What are the primary symptoms of Progressive supranuclear ophthalmoplegia?
Primary symptoms include impaired eye movement, particularly downward gaze, balance difficulties, cognitive decline, and speech issues. These symptoms progressively worsen, impacting daily functioning.
How is Progressive supranuclear ophthalmoplegia diagnosed?
Diagnosis is based on clinical evaluation, including neurological examination and patient history. Imaging studies may be used to rule out other conditions.
What treatment options are available for Progressive supranuclear ophthalmoplegia?
Treatment focuses on symptom management through physical therapy, occupational therapy, and speech therapy. There are no specific medications to halt disease progression.
Is Progressive supranuclear ophthalmoplegia a hereditary condition?
Most cases are sporadic, but some familial forms exist. Genetic counseling may be recommended for affected families.
